Affinage

TBCD

Tubulin-specific chaperone D · UniProt Q9BTW9

Length
1192 aa
Mass
132.6 kDa
Annotated
2026-04-28
19 papers in source corpus 11 papers cited in narrative 11 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

TBCD is a tubulin-specific chaperone that acts downstream of the CCT chaperonin to fold β-tubulin and assemble αβ-tubulin heterodimers, functioning within a ~200 kDa trimeric complex with ARL2 and β-tubulin in which ARL2 GTP cycling drives conformational changes in β-tubulin to regulate the folding pathway (PMID:28126905, PMID:28970104). TBCD competes with α-tubulin for β-tubulin binding and, together with TBCC, stimulates GTP hydrolysis by β-tubulin; ARL2 acts as a regulatory suppressor of TBCD's microtubule-disruptive activity (PMID:20740604, PMID:41232862). TBCD localizes to centrosomes and midbodies in a cell-cycle-dependent manner, where it coordinates centriole duplication, mitotic spindle organization, and cytokinetic abscission, and is recruited to centriolar rosettes during de novo centriole assembly in differentiating ciliated cells (PMID:20107510). Loss-of-function mutations in TBCD cause defective β-tubulin binding, accelerated microtubule polymerization, aberrant mitotic spindles, and impaired cortical neuronal proliferation and migration, underlying an early-onset encephalopathy (PMID:27666370, PMID:27666374, PMID:28158450).

Mechanistic history

Synthesis pass · year-by-year structured walk · 7 steps
  1. 2010 High

    Establishing that TBCD participates in multiple steps of the tubulin folding pathway—CCT-driven folding, tubulin disruption, and GAP-stimulated GTP hydrolysis—and that ARL2 acts as an in vivo suppressor of TBCD's microtubule-disruptive activity resolved TBCD's enzymatic roles and its regulatory relationship with ARL2.

    Evidence In vitro CCT-folding, tubulin-disruption, and GTPase assays with recombinant human/bovine TBCD, plus ARL2 siRNA knockdown in HeLa cells

    PMID:20740604

    Open questions at the time
    • Structural basis of TBCD–ARL2 interaction unknown
    • Stoichiometry and stability of native TBCD complexes not yet defined
    • TBCC contribution to GAP activity not dissected from TBCD contribution
  2. 2010 High

    Demonstrating that TBCD localizes to the daughter centriole, procentrioles, and midbody in a cell-cycle-dependent manner—and that its overexpression or depletion causes centrosomal and cytokinetic defects—established TBCD as a direct participant in centriole biogenesis and cell division beyond its cytosolic chaperone role.

    Evidence Immunofluorescence, live-cell imaging, siRNA knockdown, and overexpression in cultured cells and differentiating ciliated epithelia

    PMID:20107510

    Open questions at the time
    • Mechanism of TBCD recruitment to centrosomes and midbody not identified
    • Relationship between tubulin-folding activity and centrosomal function unclear
  3. 2016 High

    Identifying pathogenic TBCD mutations that impair β-tubulin binding, reduce soluble tubulin pools, accelerate microtubule polymerization, and disorganize mitotic spindles in patient fibroblasts established TBCD as essential for tubulin heterodimer supply and proper microtubule dynamics, linking its loss of function to human neurodevelopmental disease.

    Evidence Biochemical analyses of patient fibroblasts from multiple families, β-tubulin binding assays, microtubule polymerization assays, mitotic spindle immunofluorescence, Drosophila in vivo validation, and zebrafish morpholino knockdown

    PMID:27666370 PMID:27666374 PMID:27807845

    Open questions at the time
    • Whether disease mutations affect TBCD's centrosomal versus cytosolic functions differentially is untested
    • No structural model of mutant TBCD proteins available
  4. 2017 High

    Purification of the TBCD·ARL2·β-tubulin trimer and demonstration that ARL2 GTP exchange—not β-tubulin nucleotide cycling—drives conformational changes in β-tubulin defined the trimer as a nucleotide-regulated intermediate in the folding pathway and clarified the mechanistic basis of ARL2-mediated regulation of TBCD.

    Evidence Native gel purification from HEK cells, ARL2 point mutagenesis with microtubule density readout, HDX-MS of the trimeric complex, nucleotide-binding and exchange assays

    PMID:28126905 PMID:28970104

    Open questions at the time
    • High-resolution structure of the trimer not determined
    • Identity of the ARL2 GEF and GAP acting on the trimer in vivo unknown
    • How β-tubulin is handed off from the trimer to α-tubulin for heterodimer completion is undefined
  5. 2017 High

    In utero TBCD knockdown in mouse brain demonstrated that balanced TBCD dosage is critical for cortical neural progenitor proliferation and radial migration, connecting the tubulin-folding defect to the neurodevelopmental phenotype seen in patients.

    Evidence In utero shRNA knockdown in mouse developing cortex combined with patient fibroblast biochemistry

    PMID:28158450

    Open questions at the time
    • Whether the migration defect is cell-autonomous or involves non-cell-autonomous signaling is untested
    • Contribution of TBCD centrosomal function to the migration phenotype not dissected
  6. 2023 Medium

    CRISPR/Cas9 correction of a pathogenic TBCD mutation in patient iPSCs restored TBCD protein levels, mitotic spindle organization, and cell viability, providing direct causal evidence that the mutation is sufficient to produce the cellular disease phenotype.

    Evidence Isogenic iPSC gene correction, immunofluorescence, and cell viability assays

    PMID:37175696

    Open questions at the time
    • Rescue was not tested in differentiated neuronal lineages
    • Whether corrected cells restore normal tubulin heterodimer pools quantitatively was not shown
  7. 2025 Medium

    Demonstration that bovine TBCD competes with α-tubulin for β-tubulin binding, triggers α-tubulin degradation, and activates NF-κB/TNF-α/ROS-mediated cell death when the TBCD/β-tubulin/ARL2 trimer cannot form revealed a cytotoxic consequence of imbalanced TBCD activity and a link to inflammatory signaling.

    Evidence Co-IP, overexpression in human cell lines, RNA-seq, and in vivo tumor xenograft using bovine TBCD

    PMID:41232862

    Open questions at the time
    • Mechanism by which unbalanced tubulin ratio activates NF-κB is correlative
    • Relevance to endogenous human TBCD regulation not established
    • Single-lab finding with heterologous bovine protein

Open questions

Synthesis pass · forward-looking unresolved questions
  • Key open questions include the high-resolution structure of the TBCD·ARL2·β-tubulin trimer, the identity of the ARL2 GEF/GAP acting on this complex, the mechanism by which TBCD is recruited to centrosomes and midbodies, and whether TBCD's centrosomal and cytosolic tubulin-folding roles are separable in vivo.
  • No atomic-resolution structure of TBCD or its complexes
  • ARL2 regulators in the context of the trimer are unidentified
  • Centrosomal recruitment mechanism unknown
  • Relative contributions of folding vs. centrosomal functions to disease phenotype not dissected

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0008092 cytoskeletal protein binding 3 GO:0044183 protein folding chaperone 3 GO:0098772 molecular function regulator activity 3
Localization
GO:0005829 cytosol 2 GO:0005815 microtubule organizing center 1 GO:0005856 cytoskeleton 1
Pathway
R-HSA-1640170 Cell Cycle 3 R-HSA-392499 Metabolism of proteins 3 R-HSA-1852241 Organelle biogenesis and maintenance 1
Partners
ARL2TBCCTBCETUBB
Complex memberships
TBCD·ARL2·β-tubulin trimer

Evidence

Reading pass · 11 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2010 TBCD functions in tubulin disruption and GTPase-activating protein (GAP) assays: recombinant human TBCD participates in CCT-driven tubulin folding reactions, tubulin disruption reactions, and stimulates GTP hydrolysis by β-tubulin (together with TBCC) at heterodimer concentrations far below those required for polymerization. Bovine TBCD is produced as a stoichiometric cocomplex with β-tubulin, whereas human TBCD is not, yet both are functionally identical in vitro. siRNA-mediated suppression of ARL2 enables human TBCD to disrupt microtubule integrity in vivo, establishing ARL2 as a regulatory suppressor of TBCD activity. In vitro CCT-driven folding assay, tubulin disruption assay, GTPase assay, co-immunoprecipitation, siRNA knockdown, overexpression in HeLa cells Cytoskeleton (Hoboken, N.J.) High 20740604
2010 TBCD localizes to the centrosome and midbody in a cell-cycle-specific manner: it localizes on the daughter centriole at G1, on procentrioles by S phase, and is recruited to the midbody at telophase. TBCD overexpression causes microtubule release from the centrosome and G1 arrest; TBCD depletion produces mitotic aberrations and incomplete microtubule retraction at the midbody during cytokinesis. TBCD is recruited to centriole replication sites at the onset of centrosome duplication and forms 'centriolar rosettes' in differentiating ciliated cells, indicating roles in both canonical and de novo centriolar assembly. Immunofluorescence localization, overexpression, siRNA knockdown, live-cell imaging, analysis of ciliated cell differentiation PloS one High 20107510
2017 TBCD forms a ~200 kDa trimeric complex with the regulatory GTPase ARL2 and β-tubulin (TBCD·ARL2·β-tubulin trimer) in mouse tissues and cell lines. This trimer was purified from HEK cells and two additional novel TBCD complexes were identified. ARL2 point mutants that disrupt binding to TBCD impair proper maintenance of microtubule densities in cells, establishing that the ARL2–TBCD interaction within the trimer is critical for microtubule network maintenance. Native gel electrophoresis, immunoblotting, protein purification from HEK cells, ARL2 point mutagenesis, microtubule density quantification The Journal of biological chemistry High 28126905
2017 In the TBCD·ARL2·β-tubulin trimer, it is ARL2 (not β-tubulin) that exchanges GTP; nucleotide binding to ARL2 drives conformational changes (altered solvent accessibility) in β-tubulin as measured by hydrogen/deuterium exchange mass spectrometry. ARL2 in the trimer has increased affinity for GTP compared to ARL2 monomer, and its protein interactions resemble those of a canonical GTPase with an effector. β-tubulin in the trimer co-purifies with guanine nucleotide. This establishes the trimer as a functional intermediate in the β-tubulin folding pathway regulated by ARL2 nucleotide cycling. Hydrogen/deuterium exchange mass spectrometry (HDX-MS), nucleotide-binding assays, guanine nucleotide exchange assays Journal of molecular biology High 28970104
2016 Loss-of-function mutations in TBCD cause defective β-tubulin binding, reduced soluble α/β-tubulin levels, and accelerated microtubule polymerization in patient fibroblasts, along with aberrant mitotic spindles with disorganized, tangle-shaped microtubules and reduced aster formation. Mutant TBCD proteins show relative instability (reduced protein levels). These findings establish TBCD as required for proper microtubule dynamics through its role in αβ-tubulin heterodimer assembly. Biochemical analyses of patient fibroblasts, β-tubulin binding assays, microtubule polymerization assays, immunofluorescence of mitotic spindles, molecular dynamics simulations American journal of human genetics High 27666370
2016 Mutant TBCD proteins show impaired binding to ARL2, TBCE, and β-tubulin in vitro. In vivo experiments using Drosophila olfactory projection neurons confirmed that TBCD mutations cause loss of function. The wide range of clinical severity correlates with residual function of mutant TBCD proteins. In vitro binding assays (co-IP), Drosophila in vivo loss-of-function experiments American journal of human genetics High 27666374
2016 In utero shRNA-mediated suppression of tbcd in mouse demonstrates that a balanced supply of TBCD is critical for cortical cell proliferation and radial migration in the developing brain. Mutant TBCD proteins (A475T, A586V) have a partially compromised ability to participate in the heterodimer assembly pathway, with protein levels reduced to ~10–40% of wild type in patient fibroblasts. In utero shRNA knockdown in mouse brain, patient fibroblast biochemistry, heterodimer assembly pathway assays Human molecular genetics High 28158450
2016 Morpholino-mediated TBCD knockdown in zebrafish recapitulates key neuropathological features of human TBCD-related disease, and TBCD overexpression in zebrafish confirms an obligate dependency on proper TBCD levels during development. Morpholino knockdown in zebrafish, overexpression rescue experiments Clinical genetics Medium 27807845
2025 Bovine TBCD (bTBCD) specifically competes with α-tubulin to bind β-tubulin, resulting in degradation of α-tubulin and microtubule depolymerization. This occurs because bTBCD fails to form a functional TBCD/β-tubulin/ARL2 complex, leading to an unbalanced β/α-tubulin ratio, cell cycle arrest, and cell death via activation of non-canonical NF-κB and TNF-α signaling pathways with enhanced ROS production. Co-immunoprecipitation, overexpression in cell lines, microtubule depolymerization assays, RNA-seq, in vivo tumor xenograft International journal of biological macromolecules Medium 41232862
2023 CRISPR/Cas9 correction of a pathogenic TBCD missense mutation in patient-derived iPSCs restores proper TBCD protein levels, mitotic spindle organization, and reduces cellular death, directly linking TBCD loss to mitotic spindle defects and increased apoptosis. CRISPR/Cas9 isogenic iPSC correction, immunofluorescence of mitotic spindles, cell viability assays International journal of molecular sciences Medium 37175696
2017 TBCD and TBCE are expressed and localized in human sperm (predominantly in the middle piece and tail) and oocytes (cytosolic localization), with TBCD/TBCE mRNA present in oocytes but not in sperm, suggesting post-transcriptional regulation and a role in cytoskeletal dynamics during gametogenesis. RT-PCR, western blot, immunofluorescence in human gametes Zygote (Cambridge, England) Low 28583220

Source papers

Stage 0 corpus · 19 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2016 Biallelic Mutations in TBCD, Encoding the Tubulin Folding Cofactor D, Perturb Microtubule Dynamics and Cause Early-Onset Encephalopathy. American journal of human genetics 66 27666370
2016 Biallelic TBCD Mutations Cause Early-Onset Neurodegenerative Encephalopathy. American journal of human genetics 53 27666374
2010 Effect of TBCD and its regulatory interactor Arl2 on tubulin and microtubule integrity. Cytoskeleton (Hoboken, N.J.) 41 20740604
2017 A Trimer Consisting of the Tubulin-specific Chaperone D (TBCD), Regulatory GTPase ARL2, and β-Tubulin Is Required for Maintaining the Microtubule Network. The Journal of biological chemistry 39 28126905
2016 Infantile neurodegenerative disorder associated with mutations in TBCD, an essential gene in the tubulin heterodimer assembly pathway. Human molecular genetics 28 28158450
2010 TBCD links centriologenesis, spindle microtubule dynamics, and midbody abscission in human cells. PloS one 27 20107510
2016 Microcephaly, intractable seizures and developmental delay caused by biallelic variants in TBCD: further delineation of a new chaperone-mediated tubulinopathy. Clinical genetics 25 27807845
2017 Nucleotide Binding to ARL2 in the TBCD∙ARL2∙β-Tubulin Complex Drives Conformational Changes in β-Tubulin. Journal of molecular biology 17 28970104
2016 TBCD may be a causal gene in progressive neurodegenerative encephalopathy with atypical infantile spinal muscular atrophy. Journal of human genetics 15 27928163
2019 Developmental Regression and Epilepsy of Infancy with Migrating Focal Seizures Caused by TBCD Mutation: A Case Report and Review of the Literature. Neuropediatrics 9 31569255
2019 Biallelic pathogenic variants in TBCD-related neurodevelopment disease with mild clinical features. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 8 31240573
2018 Cortical atrophy and hypofibrinogenemia due to FGG and TBCD mutations in a single family: a case report. BMC medical genetics 7 29769041
2021 Novel Compound Heterozygous Variants in TBCD Gene Associated with Infantile Neurodegenerative Encephalopathy. Children (Basel, Switzerland) 5 34943336
2023 CRISPR/Cas9 and piggyBac Transposon-Based Conversion of a Pathogenic Biallelic TBCD Variant in a Patient-Derived iPSC Line Allows Correction of PEBAT-Related Endophenotypes. International journal of molecular sciences 3 37175696
2022 PEBAT, an Intriguing Neurodegenerative Tubulinopathy Caused by a Novel Homozygous Variant in TBCD: A Case Series and Literature Review. Pediatric neurology 3 36527993
2023 [MOH SCREENING FOR TBCD IN COCHIN JEWS: COLLABORATION BETWEEN MEDICAL, RESEARCH AND COMMUNITY MEMBERS IN ACHIEVING PUBLIC HEALTH GOALS]. Harefuah 1 37394437
2017 Expression and localization of tubulin cofactors TBCD and TBCE in human gametes. Zygote (Cambridge, England) 1 28583220
2025 Bovine tubulin cofactor D (TBCD) disrupts tubulin dimers and inhibits tumor growth via the TNF-α signaling pathways-mediated ROS production. International journal of biological macromolecules 0 41232862
2023 A Variant in TBCD Associated with Motoneuronopathy and Corpus Callosum Hypoplasia: A Case Report. International journal of molecular sciences 0 37569761